Trump Executive Order Tracker | Akin Public Policy and Lobbying

America First Investment Policy (Trump EO Tracker)

February 26, 2025

Reading Time : 2 min
Trump Executive Order Tracker | Akin Public Policy and Lobbying

Related Thought Leadership and Analysis

This memorandum directs the U.S. government to use all necessary legal instruments, including the Committee on Foreign Investment in the United States (CFIUS), to restrict PRC-affiliated persons from investing in U.S. technology, critical infrastructure, healthcare, agriculture, energy, raw materials, or other strategic sectors.  Agencies are directed to create an expedited “fast-track” process to facilitate greater investment from specified allied and partner sources in U.S. businesses involved with U.S. advanced technology and other important areas.  It requires expedited environmental reviews for any investment over $1 billion in the United States.  Additionally, the memorandum directs mitigation agreements to consist of concrete actions that companies can complete within a specific time, rather than perpetual and expensive compliance obligations.  It also states that more resources will be directed at facilitating investments from key partner countries.  

The memorandum also states that restrictions on foreign investors’ access to U.S. assets will ease in proportion to their verifiable distance and independence from the predatory investment and technology-acquisition practices of the PRC and other foreign adversaries or threat actors.  The U.S. government will continue to encourage passive investments from all foreign persons, in the form of non-controlling stakes and shares with no voting, board, or other governance rights and that do not confer any managerial influence, substantive decision-making, or non-public access to technologies or technical information, products, or services.   

The U.S. government is also directed to use all necessary legal instruments to further deter United States persons from investing in the PRC’s military-industrial sector, and consider new or expanded restrictions on United States outbound investment in the PRC in sectors such as semiconductors, artificial intelligence, quantum, biotechnology, hypersonics, aerospace, advanced manufacturing, directed energy, and other areas implicated by the PRC’s national Military-Civil Fusion strategy.

Additional Documentation

Share This Insight

Related Content

Trump Executive Order Tracker

The significant number of executive orders published by the Trump Administration cut across dozens of industries and areas of law. This searchable tool breaks down the orders and their impacts on specific industries and with in-depth analysis of specific orders.

Previous Entries

Trump Executive Order Tracker

June 3, 2026

Directs executive branch agencies to expand and implement Schedule Policy/Career, an excepted-service personnel category for career federal employees in policy-influencing positions. Transfers designated positions into Schedule Policy/Career, making employees in those roles subject to streamlined removal procedures for poor performance or misconduct while retaining merit-based hiring requirements. Amends civil service regulations, requires agencies to identify additional policy-influencing positions for potential transfer, and establishes new performance award mechanisms to incentivize high-performing employees.

...

Read More

Trump Executive Order Tracker

May 29, 2026

The Executive Order (“EO”) directs the alignment of the U.S. core childhood vaccine schedule with the best practices of peer, developed countries, while preserving access to vaccines and protecting religious freedoms and enforcing legal protections for parents. Based on a scientific assessment completed by HHS pursuant to a Presidential Memorandum dated December 5, 2025, the order notes that the U.S. currently recommends more childhood vaccines than any peer nation and identified a set of consensus vaccines consistently recommended across all peer countries. The order directs the Centers for Disease Control and Prevention (“CDC”) and its Advisory Committee on Immunization Practices (ACIP) to review the scientific assessment and take appropriate steps to update the childhood and adolescent vaccine schedule, while providing maximum flexibility to parents and doctors regarding the timing and sequencing of routine immunizations. Additionally, all immunizations on the ACIP-recommended schedule and adopted by the CDC must continue to be covered without cost sharing by private insurance, Medicaid, the Children’s Health Insurance Program, and the Vaccines for Children Program. The order also reaffirms the Administration’s commitment to fulfilling all legal obligations with respect to parental authority, religious freedom, disability accommodations, and equal protection under the law.

...

Read More

Trump Executive Order Tracker

May 1, 2026

Expands upon Executive Order 14380 that established a national emergency regarding Cuba due its threat to U.S. national security by directing the Department of State and Treasury to block U.S. trade with foreign persons designated for operating in specified sectors of the Cuban economy, imposing immigration penalties and suspending entry for designated individuals associated with the Cuban government as determined by the Department of State, and directing the Treasury Department to sanction foreign financial institutions.

...

Read More

Trump Executive Order Tracker

April 30,2026

Grants Bridger Pipeline Expansion LLC a Presidential permit to construct and operate a cross-border oil pipeline in Montana, subject to federal oversight, compliance with all applicable laws, and conditions on modification, inspection, reporting, and potential government control or removal.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.